We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$361M
AUM Growth
+$175M
Cap. Flow
-$29.7M
Cap. Flow %
-8.24%
Top 10 Hldgs %
90.77%
Holding
111
New
18
Increased
19
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$5.25M
2
TRAW icon
Traws Pharma
TRAW
+$3.96M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$1.9M
4
BPTH
Bio-Path Holdings Inc
BPTH
+$1.16M
5
TOPS icon
TOP Ships
TOPS
+$1.13M

Top Sells

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$2.9M
2
RDGT
Ridgetech Inc
RDGT
+$1.59M
3
CRMD icon
CorMedix
CRMD
+$1.59M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$1.28M
5
ATNM icon
Actinium Pharmaceuticals
ATNM
+$1.27M

Sector Composition

Rank Sector Weight
1 Healthcare 5.35%
2 Industrials 0.18%
3 Technology 0.07%
4 Consumer Discretionary 0.01%
5 Materials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTXW
101
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
– –
-631,812
Closed -$13K
BNTCW
102
DELISTED
Benitec Biopharma Limited
BNTCW
– –
-51,449
Closed -$1K
GNCA
103
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-1,481
Closed -$429K
VISL
104
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
– –
-961
Closed -$61K
CVM.WS
105
CALL
DELISTED
Cel-Sci Corp Series S
CVM.WS
– –
-187
Closed -$167K
CVM.WS
106
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
– –
-855
Closed -$764K
TEUM
107
DELISTED
Pareteum Corporation
TEUM
– –
-2,248,578
Closed -$2.9M
CYTR
108
DELISTED
CytRx Corp
CYTR
– –
-729,450
Closed -$237K
ABIL
109
DELISTED
Ability Inc
ABIL
– –
-312,642
Closed -$178K
BHVN
110
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-19,850
Closed -$828K
BHVN
111
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-412
Closed -$1.72M
1 2 3 4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sabby Management held 111 positions worth $361M, up 94% from $186M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management withdrew a net $29.7M in Q4 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Pareteum Corporation, an estimated $2.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sabby Management opened a new position in SPDR Gold Trust worth $5.37M.

  • Sabby Management's largest Q4 2019 buy was SPDR Gold Trust: 37,550 shares worth $5.37M.
  • Sabby Management added most to Traws Pharma in Q4 2019, an estimated $3.96M increase.
  • Sabby Management's biggest Q4 2019 reduction was Actinium Pharmaceuticals, cutting an estimated $1.27M.
  • Sabby Management fully exited Pareteum Corporation in Q4 2019, selling an estimated $2.9M.
  • Sabby Management's ten largest holdings make up 91% of its $361M portfolio in Q4 2019.
  • Sabby Management opened 18 new positions and closed 38 in Q4 2019.
  • Sabby Management's portfolio value rose 94% quarter-over-quarter to $361M.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.